Currently, there are 7.15B common shares owned by the public and among those 7.15B shares have been available to trade.
The company’s stock has a 5-day price change of -0.09% and 15.50% over the past three months. T shares are trading 30.10% year to date (YTD), with the 12-month market performance up to 43.71% higher. It has a 12-month low price of $14.74 and touched a high of $22.58 over the same period. T has an average intraday trading volume of 33.61 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 0.10%, 3.02%, and 17.86% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of AT&T, Inc. (NYSE: T) shares accounts for 60.53% of the company’s 7.15B shares outstanding.
It has a market capitalization of $156.53B and a beta (3y monthly) value of 0.58. The stock’s trailing 12-month PE ratio is 17.75, while the earnings-per-share (ttm) stands at $1.23. The company has a PEG of 14.79 and a Quick Ratio of 0.67 with the debt-to-equity ratio at 1.43. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.22% over the week and 1.84% over the month.
Earnings per share for the fiscal year are expected to decrease by -8.27%, and 2.56% over the next financial year. EPS should grow at an annualized rate of 1.20% over the next five years, compared to -7.15% over the past 5-year period.
Looking at the support for the T, a number of firms have released research notes about the stock. Goldman stated their Buy rating for the stock in a research note on July 01, 2024, with the firm’s price target at $22. Barclays was of a view on April 29, 2024 that the stock is Overweight, while Wolfe Research gave the stock Outperform rating on March 05, 2024, issuing a price target of $21. JP Morgan on their part issued Overweight rating on February 01, 2024.
